Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Viruses|April 16, 2014
Matrix and backstage: cellular substrates for viral vaccinesIngo Jordan, Volker Sandig
Viruses|July 4, 2012
Authentication of the R06E fruit bat cell lineIngo Jordan, Vincent J Munster, Volker Sandig
Viruses|January 23, 2013
A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined mediumIngo Jordan, Deborah Horn, Katrin John, et al.
Microorganisms|October 4, 2016
Elements in the Development of a Production Process for Modified Vaccinia Virus AnkaraIngo Jordan, Verena Lohr, Yvonne Genzel, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fucose-targeted glycoengineering of pharmaceutical cell linesChristiane Ogorek, Ingo Jordan, Volker Sandig, et al.
Vaccine|February 14, 2018
High-cell-density cultivations to increase MVA virus productionDaniel Vázquez-Ramírez, Yvonne Genzel, Ingo Jordan, et al.
Applied Microbiology and Biotechnology|February 24, 2019
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF systemDaniel Vázquez-Ramírez, Ingo Jordan, Volker Sandig, et al.
Virus Research|June 23, 2009
Cell lines from the Egyptian fruit bat are permissive for modified vaccinia AnkaraIngo Jordan, Deborah Horn, Stefanie Oehmke, et al.
Plos One|November 6, 2019
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect"Felipe Tapia, Daniel Wohlfarth, Volker Sandig, et al.
Virologica Sinica|December 14, 2019
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)Ingo Jordan, Deborah Horn, Kristin Thiele, et al.
Pageof 8